Lipid-lowering
The Future of Lipid-Lowering Therapy
17
Prevention of cardiovascular disease: plea for a rationale use of diet and lipid-lowering drugs.
3
Decline in low-density lipoprotein cholesterol concentration: lipid-lowering drugs, diet, or physical activity? Evidence from the Whitehall II study.: Predictors of declines in LDL-cholesterol
45
Primary prevention with lipid lowering drugs and long term risk of vascular events in older people: population based cohort study
9
Lipid lowering agents, cognitive decline, and dementia: the three-city study.
10
Lipid-lowering drugs associated with slower motor decline in the elderly adults.
25
LIPID LEVELS AND CARDIOVASCULAR RISK IN ELDERLY WOMEN: A GENERAL POPULATION STUDY OF THE EFFECTS OF HORMONAL TREATMENT AND LIPID-LOWERING AGENTS
23
Effects of glucose-lowering agents on vascular outcomes in type 2 diabetes: A critical reappraisal.
29
The complexity of lipoprotein (a) lowering by PCSK9 monoclonal antibodies
9
Pharmacogenomics of blood lipid regulation
24
Biogenesis and fate of lipid droplets
5
Lipid Droplets in Unicellular Photosynthetic Stramenopiles
22
Nanoparticle-lipid interaction: job scattering plots to differentiate vesicle aggregation from supported lipid bilayer formation
12
The lipid biochemistry of eukaryotic algae
97
Detergent assisted lipid extraction for biodiesel.
1
Lowering the potential of electroenzymatic glucose oxidation on redox hydrogel-modified porous carbon electrode
6
Supported lipid bilayers on biocompatible polysaccharide multilayers
27
Lipid mediators as regulators of lipid and energy metabolism during energy balance derangement in animal models
144
Proteomic Analysis of Lipid Droplets from Caco-2/TC7 Enterocytes Identifies Novel Modulators of Lipid Secretion
18
Exposure to dietary lipid leads to rapid production of cytosolic lipid droplets near the brush border membrane
16